What Are The New Weight Loss Drugs Everyone Is Talking About?

Lately, there’s been a lot of talk about weight loss drugs. So, we’re here to give you a rundown of three of the ones you’ve likely been hearing about most often: Wegovy, Ozempic and Mounjaro.

It’s no secret that maintaining a healthy weight is key to living a healthy life. Diet and exercise play crucial roles in doing so, but sometimes it’s appropriate for people to turn to medications when necessary.

The first drug we’ll look at is a 2.4mg dosage of semaglutide, brand name Wegovy, which went viral after Elon Musk credited his slim down to fasting and the drug. This injection was approved in 2021 for chronic weight management in adults with obesity and in adults who are overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) for use in addition to a reduced calorie diet and increased physical activity. But the Center for Drug Evaluation and Research expanded the population to patients aged 12 years and older in 2022. RELATED: Celebrating 170-Pound Weight Loss, Leukemia Survivor, 45, Takes Indoor Skydive– The Courage To Change Wegovy is taken as a self-administered injection once a week.

“This drug mimics a hormone that targets the areas of the brain that control appetite and can make you feel fuller sooner,” according to a post from Cedars-Sinai Medical Center. “It can help someone lose about 15% of their body weight—so a person who weighs 300 pounds could expect to lose 45 pounds.”

Ozempic, on the other hand, is a lower dosage of the drug semaglutide. It was first approved as a treatment for type 2 diabetes in 2017.

Ozempic is also a weekly injection, and it’s been in hot demand lately since many supplies ran low after the medication was touted by social media users and celebrities alike as an effective off-label substitute for Wegovy. Both Ozempic and Wegovy are medications from the pharmaceutical company Novo Nordisk.

“It really makes me mad; it infuriates me,” Shane Anthony, 57, said about having to switch from Ozempic to another medication for his type 2 diabetes. “We need it to stay alive and keep functioning on an everyday basis.”

According to the Cleveland…

Source link

About the author

Share on Social Media